Last reviewed · How we verify

NCT05545423: IASTM

Effect of Instrument-Assisted Soft Tissue Mobilization on Proprioception and Disability in Patients With Cervicogenic Headache

Status unknown NA Last updated 19 September 2022
What this trial tests

NA trial testing instrumented assisted soft tissue mobilization in Cervicogenic Headache in 80 participants. Status unknown.

Timeline
30 September 2022
Primary endpoint
30 March 2023
30 March 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment80
Start date30 September 2022
Primary completion30 March 2023
Estimated completion30 March 2023

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 35 to 50, any sex, with Cervicogenic Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to investigate the effect of instrument assisted soft tissue mobilization technique In pain intensity, frequency of headache, medication Uptake, Suboccipital movement in flexion and extension, rounded shoulder, forward head posture and proprioception of cervical spine in cases of cervicogenic headache related to trigger points and myofascial restrictions when combined with conventional physical therapy modalities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of instrumented assisted soft tissue mobilization

Trials testing the same drug.

Other recruiting trials for Cervicogenic Headache

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05545423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing